Focal segmental glomerulosclerosis is a histologic lesion, rather than a clinical disease. FSGS is common cause of nephrotic syndrome in both adults and children worldwide. In the United States it is the most common primary glomerular disease resulting in end-stage renal disease and recent reports have suggested that its incidence might be on the rise. Currently the incidence is estimated to be 7 per million. The podocyte is the cellular target cell in FSGS and in recent years substantial insight in the pathogenesis and genetics of FSGS have accumulated. Furthermore the discovery of potential novel biomarkers to diagnose FSGS and monitor disease activity has renewed interest in this disease. In this review article we will focus on the clini...
Focal segmental glomerulosclerosis (FSGS) is a heterogeneous renal histopathological entity that aff...
Focal segmental glomerulosclerosis (FSGS) is a heterogeneous renal histopathological entity that aff...
immunosuppressive therapy; podocyte Writing on the treatment of primary focal segmental glomeruloscl...
Focal segmental glomerulosclerosis is a histologic lesion, rather than a clinical disease. FSGS is c...
Focal segmental glomerulosclerosis is a histologic lesion, rather than a clinical disease. FSGS is c...
Focal segmental glomerulosclerosis (FSGS) is a well-defined pattern of glomerular injury identifiabl...
Focal and segmental glomerulosclerosis (FSGS) is a generic term that in the current terminology can ...
Focal and segmental glomerulosclerosis (FSGS) is a generic term that in the current terminology can ...
Item does not contain fulltextFocal segmental glomerulosclerosis (FSGS) is one the most important ca...
Focal segmental glomerulosclerosis (FSGS) is a glomerulopathy associated with nephrotic syndrome and...
Focal segmental glomerulosclerosis (FSGS) represents the most common primary glomerular disease resp...
Item does not contain fulltextFocal segmental glomerulosclerosis (FSGS) is not a specific disease en...
The spectrum of podocytopathies ranges from steroid-re-sponsive minimal change disease (MCD) to deva...
Focal segmental glomerulosclerosis (FSGS) is one the most important causes of the nephrotic syndrome...
Focal segmental glomerulosclerosis (FSGS) can be classified as primary or secondary. Moreover, many ...
Focal segmental glomerulosclerosis (FSGS) is a heterogeneous renal histopathological entity that aff...
Focal segmental glomerulosclerosis (FSGS) is a heterogeneous renal histopathological entity that aff...
immunosuppressive therapy; podocyte Writing on the treatment of primary focal segmental glomeruloscl...
Focal segmental glomerulosclerosis is a histologic lesion, rather than a clinical disease. FSGS is c...
Focal segmental glomerulosclerosis is a histologic lesion, rather than a clinical disease. FSGS is c...
Focal segmental glomerulosclerosis (FSGS) is a well-defined pattern of glomerular injury identifiabl...
Focal and segmental glomerulosclerosis (FSGS) is a generic term that in the current terminology can ...
Focal and segmental glomerulosclerosis (FSGS) is a generic term that in the current terminology can ...
Item does not contain fulltextFocal segmental glomerulosclerosis (FSGS) is one the most important ca...
Focal segmental glomerulosclerosis (FSGS) is a glomerulopathy associated with nephrotic syndrome and...
Focal segmental glomerulosclerosis (FSGS) represents the most common primary glomerular disease resp...
Item does not contain fulltextFocal segmental glomerulosclerosis (FSGS) is not a specific disease en...
The spectrum of podocytopathies ranges from steroid-re-sponsive minimal change disease (MCD) to deva...
Focal segmental glomerulosclerosis (FSGS) is one the most important causes of the nephrotic syndrome...
Focal segmental glomerulosclerosis (FSGS) can be classified as primary or secondary. Moreover, many ...
Focal segmental glomerulosclerosis (FSGS) is a heterogeneous renal histopathological entity that aff...
Focal segmental glomerulosclerosis (FSGS) is a heterogeneous renal histopathological entity that aff...
immunosuppressive therapy; podocyte Writing on the treatment of primary focal segmental glomeruloscl...